Introducing the ADR Spine Top Doctors in Arthroplasty Program: Pioneering the Future of Spinal Health
LOS ANGELES, CA / ACCESSWIRE / September 15, 2023 / Dr. Todd H. Lanman is pleased to announce the official...
Disability
Patients for Patient Safety US Marches for Enhanced Healthcare Accountability
Joining forces with like-minded organizations, PFPS US upholds World Patient Safety Day with a dedicated march in Washington, featuring symbolic...
Northwestern Mutual doubles down on commitment in the fight against childhood cancer, reignites social media #LemonTopChallenge for Childhood Cancer Awareness Month
Company announces additional major investments toward cancer research and scholarships and enacts local activations MILWAUKEE, Sept. 14, 2023 /PRNewswire/ --...
Pharmazz Inc. and Sun Pharma enter into licensing agreement for introducing Tyvalzi™ (Sovateltide) in India
Sovateltide is a first of its kind drug to treat acute cerebral ischemic stroke that can be administered up to...
Joni and Friends Partners with the State Fair of Texas for Sensory-Friendly Morning
Wednesday, October 4th, 10:00 A.M. - 1:00 P.M.DALLAS, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Joni and Friends, a global non-profit...
LanguageLine Solutions Integrates With VidaTalk, Pioneering Seamless Language Access for Healthcare Patients and Providers
ANN ARBOR, MI / ACCESSWIRE / September 13, 2023 / LanguageLine Solutions, the world leader in language access and interpretation...
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
PARIS, FRANCE / ACCESSWIRE / September 12, 2023 / Ad Scientiam, a global leader in digital biomarkers, has announced a...
NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS
CARMEL, Ind., Sept. 12, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
New Test Analyzes Highly Curated Set of 236 Genes Most Associated with Autism Spectrum Disorder, Intellectual Disabilities, and Developmental Delay.HOUSTON,...
CURAPROX Launches Samba, The World’s First Robotic Toothbrush Created Explicitly for the Disabled Community
Leading Swiss oral health brand introduces innovative solution to empower individuals with disabilities to achieve independent oral care MESA, Ariz.,...
Theralase Release’s 2Q2023 Interim Financial Statements
TORONTO, ON / ACCESSWIRE / August 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Quantum Health Announces New Clinical Advisory Boards To Expand Musculoskeletal and Behavioral Health Clinical Support for Members
Quantum Health’s newly added clinical advisory boards will launch in 2024 to expand the company’s strategic clinical guidance for musculoskeletal...
Taysha Gene Therapies Announces Fast Track Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
Fast Track Designation (FTD) is designed to accelerate the development and expedite the review of therapies with potential to address...
NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome
CARMEL, Ind., Aug. 22, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology...
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
Presentations Highlight New Data on Diagnostic Accuracy and Novel Biomarkers of Disease Severity in Multiple System AtrophyMELBOURNE, Australia and SAN...
IRLAB Provides Update on Mesdopetam’s Phase IIb Study Data and the Plans Toward Phase III
GOTHENBURG, SE / ACCESSWIRE / August 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for...
GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine
STAMFORD, Conn., Aug. 21, 2023 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical...
FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023
Targeting the Approximate $22 Billion Multiple Sclerosis Drug Treatment MarketTORONTO, ON / ACCESSWIRE / August 15, 2023 / FSD Pharma...
BioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder
Company Hopes in 30 Days to Begin Making Its Drug Candidate Available to Help Patients and Address Public Health Crisis...
Oasis Cannabis Utilizing AI-Powered Budtender Offering Personalized Recommendations & ChatGPT Agent
LAS VEGAS, NV / ACCESSWIRE / August 8, 2023 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a...